bioRxiv preprint doi: https://doi.org/10.1101/653857; this version posted May 29, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Genetic editing of SEC61, SEC62, and 2 SEC63 abrogates human cytomegalovirus 3 US2 expression in a signal peptide- 4 dependent manner 5 6 7 Anouk B.C. Schuren 1, Ingrid G.J. Boer1, Ellen Bouma1,2, Robert Jan Lebbink1, Emmanuel 8 J.H.J. Wiertz 1,* 9 1Department of Medical Microbiology, University Medical Center Utrecht, 3584CX Utrecht, The Netherlands. 10 2 Current address: Department of Medical Microbiology, University Medical Center Groningen, Postbus 30001, 9700 RB 11 Groningen, The Netherlands 12 *Correspondence:
[email protected] (E.J.H.J.W.) 13 14 Abstract 15 Newly translated proteins enter the ER through the SEC61 complex, via either co- or post- 16 translational translocation. In mammalian cells, few substrates of post-translational SEC62- and 17 SEC63-dependent translocation have been described. Here, we targeted all components of the 18 SEC61/62/63 complex by CRISPR/Cas9, creating knock-outs or mutants of the individual subunits of 19 the complex. We show that functionality of the human cytomegalovirus protein US2, which is an 1 bioRxiv preprint doi: https://doi.org/10.1101/653857; this version posted May 29, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.